A Non-Destructive Methodological Framework for Modernizing Legacy Clinical Reporting Systems for AI-Driven Pharmacoinformatics: A SAS Case Study
As the pharmaceutical industry evolves, the integration of artificial intelligence (AI) into clinical reporting systems has become increasingly critical. However, many organizations still rely on legacy systems that pose significant challenges for modernization. This article discusses a breakthrough in addressing these issues through a non-destructive methodological framework, as detailed in the recent arXiv publication (arXiv:2605.13905v1).
The Challenge of Legacy Clinical Reporting Systems
Drug development and pharmacovigilance processes are often hampered by outdated clinical reporting pipelines. These monolithic systems are built on regulatory-grade logic but lack the flexibility necessary for AI integration. The primary issues include:
- Opaque Output: Traditional systems produce results that are not easily interpretable or machine-readable.
- Structural Barriers: Existing modernization strategies typically require a choice between a complete system rewrite and incremental refactoring, neither of which adequately addresses the integration of AI.
An Innovative Solution
The proposed framework offers a novel approach to achieving AI-driven pharmacoinformatics readiness without the need to alter existing legacy source code. Central to this methodology is the introduction of a metadata layer that includes:
- Bridge Map: This component connects legacy systems with modern AI tools.
- Typed Intermediate Representation (IR): A structured format that enables data to be processed by large language models (LLMs).
- Orchestrator: This manages the flow of data between legacy components and new AI functionalities.
This metadata layer serves as a wrapper for existing components, re-exposing their outputs as structured data that can be consumed by AI systems. Additionally, it allows for optional incremental consolidation, meaning organizations can replace selected legacy components with modernized core routines while retaining the functionality of the remaining systems.
Case Study: Validated on SAS Reporting Library
The framework was validated using a 558-component SAS reporting library, comprising approximately 373,000 lines of code. The results demonstrated immediate AI-readiness under a coexistence model, yielding machine-readable outputs. Key findings included:
- Reduction in Proprietary Code: When consolidation was implemented, the modernized core achieved a remarkable 92% reduction in proprietary code.
- Parity Validation: A comparison on 14 report types from a Phase III study revealed cell-level parity of 80% or above on 11 reports, with a mean of 82.7% and a best result of 99.2%.
- Benchmarking Success: A benchmark test using CDISC CDISCPilot01 data achieved 100% parity across five reports.
Impact on Pharmacovigilance and Drug Development
Experiments with LLMs confirmed that the Intermediate Representation enables various applications, including:
- Automated pharmacovigilance
- Table summarization
- Trial configuration generation
This innovative framework provides a regulation-aware pathway to integrate AI into clinical reporting processes, significantly accelerating drug development while ensuring compliance with regulatory submissions.
Conclusion
The implementation of a non-destructive methodological framework for modernizing legacy clinical reporting systems marks a significant advancement in the field of pharmacoinformatics. By bridging the gap between traditional systems and modern AI capabilities, this approach empowers pharmaceutical companies to enhance their reporting processes without disruption.
Related AI Insights
- OpenDeepThink: Boost LLM Reasoning with Bradley-Terry Model
- Uncommon Self-Knowledge: A New Framework for Consciousness
- Orchard: Open-Source Framework for Agentic AI Modeling
- Small Language Models for Private Educational Assessment Design
- Spectral Analysis for Effective Fake News Detection
- CAST Framework: Enhancing LLM Tool Use with Case-Based Calibration
- ARES-LSHADE: Advanced Evolutionary Algorithm for GNBG
- Large Language Models Enhancing Web Accessibility
- GAMBIT Benchmark: Testing Adversarial Robustness in Multi-Agent AI
- Smartphone Touchscreen EM Attacks: Handwriting Recovery Risk
